VIROLOGIC OUTCOMES OF LAMIVUDINE/DOLUTEGRAVIR IN VIROLOGICALLY SUPPRESSED SUBJECTS WITH EXPECTED OR CONFIRMED RESISTANCE TO LAMIVUDINE

• ACRONYM: VOLVER
• FSG CODE: GESIDA 11820
• COORDINATOR: JOSÉ RAMÓN ARRIBAS LÓPEZ / FEDERICO PULIDO
• COORDINATOR’S HOSPITAL: HOSPITAL UNIVERSITARIO LA PAZ, MADRID / HOSPITAL UNIVERSITARIO 12 DE OCTUBRE, MADRID 
• APPROVAL DATE: 22-JUL.-2020
• PROTOCOL STATUS: ANALYZING DATA / PUBLISHED 
• CEIC-S APPROVAL: YES
• AEMYPS APPROVAL: YES
• ENROLED PATIENTS: 121
• TOTAL NUMBER OF PATIENTS TO INCLUDE: 120
• SCIENTIFIC OUTPUT: PUBLISHED